Inflammatory breast cancer
Overview
Inflammatory breast cancer is a form of breast cancer that causes breast swelling and skin changes.
Inflammatory breast cancer happens when a growth of cells forms in the breast tissue. The cells break away from where they start to grow and travel to the lymphatic vessels in the skin. The cells can block the vessels and cause the skin on the breast to look swollen. This skin on the breast might look pink, red, purple or bruised, depending on your skin color.
Inflammatory breast cancer is considered a locally advanced cancer. When a cancer is locally advanced, that means it has spread from where it started to nearby tissue and possibly to nearby lymph nodes.
Inflammatory breast cancer can easily be confused with a breast infection, which is a much more common cause of breast swelling and skin changes. Seek medical attention right away if you notice skin changes on your breast.
Inflammatory breast cancer is different from more common types of breast cancer because it usually develops rapidly, often does not form a distinct lump, and is already locally advanced when it is diagnosed. The swelling and skin changes happen when cancer cells block lymph vessels in the skin of the breast.
Symptoms
Inflammatory breast cancer doesn't commonly form a lump, as occurs with other forms of breast cancer. Instead, signs and symptoms of inflammatory breast cancer include:
For inflammatory breast cancer to be diagnosed, these symptoms must have been present for less than six months.
The skin changes of inflammatory breast cancer may look pink, red, purple or bruised, depending on your skin color. The affected area may be swollen, warm, thickened or dimpled, and it may look and feel like an orange peel. The breast also may have a heavy, tender, painful or burning feeling. These changes usually develop quickly over several weeks to months and often involve at least one-third of the breast.
Inflammatory breast cancer usually affects one breast. One breast may become larger, warmer or heavier than the other. A lump is not common, though some people may have an underlying mass.
Men can get inflammatory breast cancer because men have breast tissue. In men, inflammatory breast cancer may cause rapid breast swelling, a change in skin color, warmth and tenderness. It does not cause a lump. Inflammatory breast cancer is very rare in men. Learn more about male breast cancer.
Make an appointment with a doctor or other healthcare professional if you have any symptoms that worry you.
Other, more common conditions have symptoms similar to those of inflammatory breast cancer. A breast injury or breast infection, called mastitis, may cause skin color changes, swelling and pain.
Inflammatory breast cancer can easily be confused with a breast infection, which is much more common. It's reasonable and common to first be treated with antibiotics for a suspected breast infection. If the condition does not improve, your healthcare professional may consider more-serious causes of your symptoms, such as inflammatory breast cancer.
If you've been treated for a breast infection but your symptoms continue, contact your healthcare professional. You may have a mammogram or other test to evaluate your symptoms. The only way a healthcare professional can know whether your symptoms are caused by inflammatory breast cancer is to remove a sample of tissue for testing.
Mastitis and other breast infections can cause a change in skin color, warmth, swelling, tenderness and itching that resemble inflammatory breast cancer. Mastitis is especially common during breastfeeding. A breast injury also can cause swelling, pain and skin color changes. If treatment for a suspected infection does not improve symptoms, or if the affected area gets larger or symptoms worsen, contact your healthcare professional for more testing.
Paget's disease of the breast can cause scaly, crusted, itchy or irritated skin that usually begins on the nipple and may spread to the darker skin around it. Eczema and contact dermatitis can cause similar nipple or skin changes. These conditions are different from inflammatory breast cancer, but persistent breast or nipple changes need medical evaluation.
Causes
Inflammatory breast cancer happens when cells in the breast develop changes in their DNA. A cell's DNA holds the instructions that tell the cell what to do. In healthy cells, the DNA gives instructions to grow and multiply at a set rate. The instructions tell the cells to die at a set time. In cancer cells, the DNA changes give different instructions. The changes tell the cancer cells to make many more cells quickly. Cancer cells can keep living when healthy cells would die. This causes too many irregular cells to build up.
Most often, the DNA changes happen in a cell in one of the tubes, called ducts, that can carry breast milk to the nipple. But the cancer also can begin with a cell in the glandular tissue, called lobules, where breast milk can be produced.
In inflammatory breast cancer, the cancer cells break away from where they started. They travel to the lymphatic vessels in the breast skin. The cells collect in and clog the vessels. The blockage in the lymphatic vessels causes skin color changes, swelling and dimpled skin, giving the appearance of an orange peel. This skin change is a classic sign of inflammatory breast cancer.
Risk factors
Factors that raise the risk of inflammatory breast cancer include:
Women are much more likely than men to get breast cancer, including inflammatory breast cancer. Everyone is born with some breast tissue, so anyone can get breast cancer.
Inflammatory breast cancer is more frequently diagnosed in people in their 40s and 50s.
Black people have a higher risk of inflammatory breast cancer than do white people.
People who have obesity have a greater risk of inflammatory breast cancer.
Prevention
Making changes in your daily life may help lower your risk of breast cancer. Try to:
Become familiar with your breasts through breast self-exam for breast awareness. You may choose to become familiar with your breasts by occasionally inspecting them during a breast self-exam for breast awareness. If you find a change, lumps or other unusual signs in your breasts, tell a healthcare professional right away.
Breast awareness can't prevent breast cancer. But it may help you to better understand the look and feel of your breasts. This might make it more likely that you'll notice if something changes.
Diagnosis
Inflammatory breast cancer is a clinical diagnosis that often starts with a discussion of your health history and an exam of the breast. Other tests include imaging tests and removing some cells for testing, called a breast biopsy.
Tests and procedures used to diagnose inflammatory breast cancer include:
If you're diagnosed with inflammatory breast cancer, you may have other tests to see if the cancer has spread. These tests help your healthcare team find out the extent of your cancer, also called the stage. Cancer staging often involve imaging tests. The tests might look for signs of cancer in your lymph nodes or in other parts of your body. Your healthcare team uses results of the cancer staging tests to help create your treatment plan.
Imaging tests may include an MRI, a CT scan, a bone scan and a positron emission tomography (PET) scan. Not every test is right for every person. Talk with your healthcare professional about which tests are best for you.
The stages of breast cancer range from 0 to 4. Inflammatory breast cancer is different: It is always diagnosed as stage 3 or stage 4 because it involves the skin of the breast. Stage 3 means the cancer has not spread to distant parts of the body. Stage 4 means it has spread to distant areas, such as the lungs, liver, bones or brain.
Treatment
Inflammatory breast cancer treatment begins with chemotherapy. If the cancer hasn't spread to other areas of the body, treatment continues with surgery and radiation therapy. If the cancer has spread to other areas of the body, your healthcare team may recommend other medicines in addition to chemotherapy. These treatments can slow the growth of the cancer.
Chemotherapy treats cancer with strong medicines. You may receive chemotherapy medicines through a vein, in pill form or both.
Chemotherapy for breast cancer is used before surgery for inflammatory breast cancer. This presurgical treatment, called neoadjuvant therapy, aims to shrink the cancer before surgery. Neoadjuvant chemotherapy increases the chance that surgery will be successful.
If your cancer has a high risk of returning or spreading to another part of your body, your healthcare professional may recommend additional treatment after you've completed other treatments. This may include chemotherapy, biological therapy for cancer, targeted treatment for breast cancer or hormone therapy for breast cancer, depending on the cancer's biomarkers and response to treatment. Biomarkers are features of cancer cells that can help guide treatment choices.
After chemotherapy, you may have surgery to remove the affected breast and some of the nearby lymph nodes. The operation usually includes:
Talk with your healthcare team about your options for breast reconstruction. Surgery to reconstruct the breast is often delayed until after you complete all of your breast cancer treatments.
You may have different options for reconstruction, including breast reconstruction with flap surgery, transverse rectus abdominis muscle (TRAM) flap surgery and breast reconstruction with implants. Your healthcare team can tell you what options may be best for your situation.
Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy for breast cancer, you lie on a table while a machine moves around you. The machine directs radiation to precise points in your body.
For inflammatory breast cancer, radiation therapy is used after surgery to kill any cancer cells that might remain. The radiation is aimed at your chest, armpit and shoulder.
Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die.
For example, several targeted therapy medicines focus on a protein that some breast cancer cells make too much of. This protein is called human epidermal growth factor receptor 2 (HER2). The protein helps breast cancer cells grow and survive. By targeting cells that make too much HER2, targeted therapy medicines can damage cancer cells while sparing healthy cells.
If your inflammatory breast cancer cells test positive for HER2, your healthcare team might recommend combining targeted therapy with your initial chemotherapy treatment. After surgery, targeted therapy can be combined with hormone therapy.
For cancer that spreads to other parts of the body, called metastatic breast cancer, targeted therapy medicines are available that focus on other changes within cancer cells. Your cancer cells may be tested to see which targeted therapies might be helpful for you.
Hormone therapy is used to treat breast cancers that use the body's hormones to grow. Healthcare professionals refer to these cancers as estrogen receptor (ER) positive breast cancer and progesterone receptor (PR) positive breast cancer.
Hormone therapy for breast cancer can be used after surgery or other treatments to decrease the chance of the cancer returning. If the cancer has already spread, hormone therapy may shrink and control it.
Treatments that can be used in hormone therapy include:
Immunotherapy, also called biological therapy for cancer, is a treatment with medicine that helps the body's immune system kill cancer cells. The immune system fights off diseases by attacking germs and other cells that shouldn't be in the body. Cancer cells survive by hiding from the immune system. Immunotherapy helps the immune system cells find and kill the cancer cells.
Immunotherapy might be an option if your cancer has spread to other areas of the body and is triple negative. In triple-negative breast cancer (TNBC), the cancer cells don't have receptors for HER2 or the hormones estrogen or progesterone. Your healthcare professional may test your cancer cells to see if they're likely to respond to immunotherapy.
Palliative care is a special type of healthcare that helps people with serious illnesses feel better. If you have cancer, palliative care can help relieve pain and other symptoms. A team of healthcare professionals gives palliative care. This can include doctors, nurses and other specially trained professionals. Their goal is to improve the quality of life for you and your family.
Palliative care specialists work with you, your family and your care team to help you feel better. They provide an extra layer of support while you have cancer treatment. You can have palliative care at the same time as strong cancer treatments, such as surgery, chemotherapy or radiation therapy.
When palliative care is used along with other treatments, people with cancer may feel better and live longer.
Coping and support
Inflammatory breast cancer progresses rapidly. Sometimes this means you need to start treatment before you've had time to think everything through. With time, you'll find what helps you cope with the uncertainty and distress of a cancer diagnosis. Until then, you may find that it helps to:
Ask your healthcare team about support groups in your area. Other sources of information include the National Cancer Institute and the American Cancer Society.
Preparing for an appointment
Make an appointment with a doctor or other healthcare professional if you have any symptoms that worry you.
If you're diagnosed with inflammatory breast cancer, you'll be referred to a doctor who specializes in treating cancer, called an oncologist.
Because appointments can be brief, it's a good idea to be prepared. Here's some information to help you get ready.
A little preparation can help you make the most of your appointment.
Your time with your healthcare team is limited, so preparing a list of questions can help you make the most of your time together. List your questions from most important to least important in case time runs out. For inflammatory breast cancer, some basic questions to ask include:
Don't hesitate to ask other questions.
Be prepared to answer questions, such as:
Stages
Cancer staging describes the extent of cancer in the body. It helps the healthcare team plan treatment, estimate the prognosis and determine whether clinical trials may be appropriate. Inflammatory breast cancer grows and spreads quickly. Symptoms often develop over several weeks, and the defining breast changes must have begun within the past six months to be considered inflammatory breast cancer.. Unlike many other breast cancers, inflammatory breast cancer is always stage 3 or stage 4 when diagnosed.
Breast cancer staging uses information about the tumor, nearby lymph nodes and whether the cancer has spread to distant parts of the body. This is called the TNM system: T describes the primary tumor, N describes nearby lymph nodes, and M describes distant metastasis.
Breast cancer staging uses information about the tumor, nearby lymph nodes and whether the cancer has spread to distant parts of the body. This is called the TNM system: T describes the primary tumor, N describes nearby lymph nodes and M describes whether the cancer has spread to a distant part of the body. Biomarker tests look for features of the cancer cells, including estrogen receptor, progesterone receptor and HER2 status. These results help guide treatment. Inflammatory breast cancer is classified as T4d because it involves the breast skin. It cannot be stage 1 or stage 2. Stage 3 means the cancer has not spread to a distant part of the body. Stage 4 means the cancer has spread to a distant part of the body.
Staging tests help your healthcare team confirm the diagnosis, find out how far the cancer has spread and plan treatment.
The healthcare team combines the exam, biopsy, biomarker and imaging results to assign stage 3 or stage 4.
Stage 3 inflammatory breast cancer has spread into the skin of the breast and may involve nearby lymph nodes or nearby structures. The cancer has not spread to distant parts of the body. It is considered locally advanced cancer.
Because inflammatory breast cancer can progress rapidly, treatment usually begins soon after diagnosis. The typical approach is chemotherapy for breast cancer or other systemic treatment before surgery. This is followed by a modified radical mastectomy, which removes the affected breast and nearby lymph nodes, and radiation therapy for breast cancer. Targeted therapy, hormone therapy for breast cancer or biological therapy for cancer may be added based on the cancer's biomarkers.
Stage 4 inflammatory breast cancer, also called metastatic inflammatory breast cancer, has spread beyond the breast and nearby lymph nodes to a distant part of the body. This includes areas such as the bones, lungs, liver or brain. The speed and pattern of spread vary from person to person. Inflammatory breast cancer is more likely than many other breast cancers to have already spread when it is diagnosed.
Treatment usually focuses on medicines that work throughout the body, such as chemotherapy, breast cancer hormone therapy, targeted therapy or immunotherapy. Radiation therapy or surgery may be used in selected situations to relieve symptoms or control cancer in a specific area. Treatment choices depend on biomarkers, previous treatment, symptoms and the parts of the body affected.
Survival rates
Five-year relative survival rates for women with inflammatory breast cancer are 53% when the cancer has spread to nearby lymph nodes or tissues and 22% when it has spread to distant parts of the body. These categories are called regional disease and distant disease in survival statistics. Regional disease generally corresponds to stage 3 inflammatory breast cancer. Distant disease corresponds to stage 4. Survival statistics do not include a localized category for inflammatory breast cancer because the cancer already involves the breast skin when it is diagnosed.
A five-year relative survival rate compares people with the same type and extent of cancer with people in the overall population. For example, a 53% five-year relative survival rate means that people with regional inflammatory breast cancer are about 53% as likely as people without that cancer to be alive five years after diagnosis.
It's important to remember that survival rates describe groups of people treated in the past. They cannot predict exactly what will happen for one person in the future. Your healthcare team can explain what these survival statistics may mean for you.
Inflammatory breast cancer is serious because it grows and spreads quickly and is often diagnosed at an advanced stage. Stage 3 inflammatory breast cancer may be treated with the goal of removing all the cancer and preventing it from returning. Stage 4 inflammatory breast cancer generally is not considered curable, but treatment may slow its growth and help people live longer. Treatment focuses on managing the cancer, easing symptoms and maintaining quality of life.
Factors that can affect prognosis include the cancer's stage, hormone receptor and HER2 status, overall health, how well treatment works, and whether the cancer returns after treatment. Following the treatment plan and keeping follow-up appointments help the care team assess the cancer's response, manage side effects and watch for recurrence. Ask your healthcare team what the statistics may mean in your situation and whether a clinical trial may be an option.
Treatment can affect daily life and quality of life. Supportive and palliative care can help manage symptoms and treatment effects. Ongoing research and newer treatments may improve outcomes beyond those reflected in older survival data.
Updated on Aug 20, 2026
© 2023 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use